ArticlePLOS digital health2025
Phytochemical profiling and GC-MS analysis of bioactive compounds in methanolic crude extract of Beta vulgaris (BV) root from Bangladesh.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Beta vulgaris (BV) is distributed worldwide and has long been used as a culinary and in traditional medicine to treat diseases. The objective of the present study was to investigate the phytochemical constituents and the chemical fingerprinting of BV root of Bangladeshi origin. We performed qualitative conventional lab tests of colorimetric reactions with specific reagents to identify the presence of various phytochemical classes like alkaloids, flavonoids, saponins, carbohydrates, reducing sugars, tannins and steroids. To gain comprehensive insights into the chemical composition, we used gas chromatography and mass spectroscopy analysis (GC-MS). Finally, we employed computational methodologies, leveraging in‑silico physicochemical properties, pharmacokinetics, drug-likeness and medicinal chemistry friendliness analysis to identify compounds with favorable properties, increasing the likelihood of successful drug development. Phytochemical screening indicated that methanolic extract is rich in alkaloids, tannins, flavonoids, saponins, triterpenes, glycosides and carbohydrates. GC-MS analysis revealed the presence of 69 chemicals, including alkaloids and amines, amino acids and derivatives, esters, and carbohydates. The annotation of the biological function of these compounds revealed many of them or their derivatives have reported disease-modifying functions (e.g., antidiabetic, antioxidant, anti-inflammatory, anticancer, cardioprotective, etc.). Further, cheminformatics analysis revealed that at least 20 molecules (e.g., 5-(hydroxymethyl)-2-Pyrrolidinone, Pidolic acid, etc) possess not only higher concentration in beetroot but also a favorable profile for drug development. Overall, our findings of the present study contribute to understanding that the BV root can be used as a valuable source in the field of natural products drug discovery.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.